Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShield™.

Find out more about Aptar Pharma, your trusted drug delivery solutions partner

全球分布

各地区组织自己的生产和销售,地区涵盖北美、亚洲、欧洲和拉美,并有专门的全球和地方开发团队的支持

找到我们

Scientific webinar

产品新闻

产品新闻

产品新闻

最新消息

Aptar Submits Application for Emergency Use Authorization to the German Regulatory Agency BfArM for ActivShieldTM FFP2 Decontamination System 阅读全文
Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies 阅读全文
Aptar Pharma is an Outstanding Issue Sponsor in April's ONdrugDelivery 阅读全文
查看所有新闻